Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Breast Neoplasms × Nutrition Assessment × Clear all

Phase

Phase NA 7 Phase 3 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Weight Loss 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Motor Activity 1 Lung Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Intraductal, Noninfiltrating 1 Cachexia 1 Breast Neoplasms 1 Body Weight 1

Interventions

Trastuzumab 250 Cyclophosphamide 211 Paclitaxel 208 Docetaxel 201 Capecitabine 156 Letrozole 136 Carboplatin 131 Doxorubicin 121 Fulvestrant 120 Bevacizumab 102 Tamoxifen 85 Anastrozole 85 Vinorelbine 79 exemestane 75 Epirubicin 75 Gemcitabine 72 Lapatinib 70 pertuzumab 68 Radiotherapy 62 Albumin-Bound Paclitaxel 61 pembrolizumab 58 eribulin 50 palbociclib 49 Cisplatin 47 130-nm albumin-bound paclitaxel 45 Everolimus 41 Neoadjuvant Therapy 37 Goserelin 36 Taxes 35 pyrotinib 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01621659 2024-07-19

TITAN

University of Alberta

Phase 2 Active not recruiting

Breast Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡